TherapeuticsMD: Q3 Earnings Snapshot
TherapeuticsMD Announces Third Quarter 2026 Financial Results
TherapeuticsMD Announces Second Quarter 2026 Financial Results
TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY
TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger
TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY
TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY
TherapeuticsMD Announces Third Quarter 2025 Financial Results
TherapeuticsMD Q3 Sales $784.000K Up From $547.000K YoY
TherapeuticsMD Continues To Evaluate A Variety Of Strategic Alternatives
TherapeuticsMD: Q2 Earnings Snapshot
TherapeuticsMD Announces Second Quarter 2025 Financial Results
TherapeuticsMD Q2 EPS $0.05 Up From $(0.09) YoY, Sales $1.000M Up From $234.000K YoY
TherapeuticsMD: Q1 Earnings Snapshot
TherapeuticsMD Announces First Quarter 2025 Financial Results
TherapeuticsMD Q1 EPS $(0.06) Up From $(0.07) YoY, Sales $393.00K Up From $313.00K YoY
TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023)
TherapeuticsMD Announces Full Year 2024 Financial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.